First Episealer® Talus surgery planned in Spain
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Spain has been scheduled. “We are continuing to execute on our international strategy, and I am pleased with having the first Episealer® Talus surgery in Spain scheduled. This also means that during 2021, we have had customers in 15 countries globally. Given that we are still early on our development curve, I believe that says something about our level om ambition”, says Pål Ryfors, CEO Episurf Medical.